“Ketamine is helpful as a medicine, but there’s so much more to be gained by adding the psychotherapy component,” says Dr Reid Robison, Novamind’s chief medical officer.
The extractors at Prospiant answer the key questions and considerations for extraction operators, regardless of whether you are just starting up a business or expanding multi-state locations.
Led by experienced natural products chemists, Psilera Bioscience is on a mission to create new, next-generation psychedelic medicines that can better serve patients’ needs.
To find out more about the latest air filtering options for cannabis cultivators, Analytical Cannabis spoke to Marc Byers, president of the odor mitigation company Byers Scientific.
Connor Hutcherson, a field applications scientist at Pall Corporation, outlines what farmers and producers should be aware of before entering the CBD market.
Ahead of Canada's third anniversary of cannabis legalization, Michael J. Armstrong, an associate professor at Goodman School of Business, Brock University, unpacks just how legalization rolled out across the country.
To address this, two British ambulance services are now participating in a new trial to investigate whether ketamine injections may be a more effective relief treatment for severe injury pain than the current treatment options available to Britain’s first responders.
Mydecine Innovations Group has announced its partnership with the renowned psychedelic science researcher Dr Matthew Johnson of Johns Hopkins University to carry the clinical trial.